Your browser doesn't support javascript.
loading
Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying.
Hayashi, Yujiro; Toyomasu, Yoshitaka; Saravanaperumal, Siva Arumugam; Bardsley, Michael R; Smestad, John A; Lorincz, Andrea; Eisenman, Seth T; Cipriani, Gianluca; Nelson Holte, Molly H; Al Khazal, Fatimah J; Syed, Sabriya A; Gajdos, Gabriella B; Choi, Kyoung Moo; Stoltz, Gary J; Miller, Katie E; Kendrick, Michael L; Rubin, Brian P; Gibbons, Simon J; Bharucha, Adil E; Linden, David R; Maher, Louis James; Farrugia, Gianrico; Ordog, Tamas.
Afiliação
  • Hayashi Y; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Toyomasu Y; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Saravanaperumal SA; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Bardsley MR; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Smestad JA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
  • Lorincz A; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Eisenman ST; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota.
  • Cipriani G; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota.
  • Nelson Holte MH; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
  • Al Khazal FJ; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
  • Syed SA; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; Department of Biochemistry and Mole
  • Gajdos GB; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Choi KM; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota.
  • Stoltz GJ; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
  • Miller KE; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
  • Kendrick ML; Department of Surgery, Mayo Clinic, Rochester, Minnesota.
  • Rubin BP; Departments of Anatomic Pathology and Cancer Biology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Lerner Research Institute and Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio.
  • Gibbons SJ; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
  • Bharucha AE; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
  • Linden DR; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
  • Maher LJ; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
  • Farrugia G; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota.
  • Ordog T; Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: ordog.tamas@mayo.edu.
Gastroenterology ; 153(2): 521-535.e20, 2017 08.
Article em En | MEDLINE | ID: mdl-28438610
BACKGROUND & AIMS: Depletion of interstitial cells of Cajal (ICCs) is common in diabetic gastroparesis. However, in approximately 20% of patients with diabetes, gastric emptying (GE) is accelerated. GE also occurs faster in obese individuals, and is associated with increased blood levels of glucose in patients with type 2 diabetes. To understand the fate of ICCs in hyperinsulinemic, hyperglycemic states characterized by rapid GE, we studied mice with mutation of the leptin receptor (Leprdb/db), which in our colony had accelerated GE. We also investigated hyperglycemia-induced signaling in the ICC lineage and ICC dependence on glucose oxidative metabolism in mice with disruption of the succinate dehydrogenase complex, subunit C gene (Sdhc). METHODS: Mice were given breath tests to analyze GE of solids. ICCs were studied by flow cytometry, intracellular electrophysiology, isometric contractility measurement, reverse-transcription polymerase chain reaction, immunoblot, immunohistochemistry, enzyme-linked immunosorbent assays, and metabolite assays; cells and tissues were manipulated pharmacologically and by RNA interference. Viable cell counts, proliferation, and apoptosis were determined by methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, and caspase-Glo 3/7 assays. Sdhc was disrupted in 2 different strains of mice via cre recombinase. RESULTS: In obese, hyperglycemic, hyperinsulinemic female Leprdb/db mice, GE was accelerated and gastric ICC and phasic cholinergic responses were increased. Female KitK641E/+ mice, which have genetically induced hyperplasia of ICCs, also had accelerated GE. In isolated cells of the ICC lineage and gastric organotypic cultures, hyperglycemia stimulated proliferation by mitogen-activated protein kinase 1 (MAPK1)- and MAPK3-dependent stabilization of ets variant 1-a master transcription factor for ICCs-and consequent up-regulation of v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) receptor tyrosine kinase. Opposite changes occurred in mice with disruption of Sdhc. CONCLUSIONS: Hyperglycemia increases ICCs via oxidative metabolism-dependent, MAPK1- and MAPK3-mediated stabilization of ets variant 1 and increased expression of KIT, causing rapid GE. Increases in ICCs might contribute to the acceleration in GE observed in some patients with diabetes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Proto-Oncogênicas c-kit / Sistema de Sinalização das MAP Quinases / Proteínas de Ligação a DNA / Células Intersticiais de Cajal / Esvaziamento Gástrico / Hiperglicemia Limite: Animals / Female / Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Proto-Oncogênicas c-kit / Sistema de Sinalização das MAP Quinases / Proteínas de Ligação a DNA / Células Intersticiais de Cajal / Esvaziamento Gástrico / Hiperglicemia Limite: Animals / Female / Humans Idioma: En Revista: Gastroenterology Ano de publicação: 2017 Tipo de documento: Article